Key facts
- This page summarizes Accelmed Partners II L.P.'s Form 4 filing for NeuroPace Inc (NPCE).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 23 Nov 2022, 16:29.
Accelmed Partners II L.P. - 21 Nov 2022 Form 4 Insider Report for NeuroPace Inc (NPCE)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- NPCE
- Reported as of
- 21 Nov 2022
- Net transaction value
- +$585,046
- SEC form
- 4
- Accepted by SEC
- 23 Nov 2022, 16:29:37 UTC
- Next SEC filing
- 09 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Uri Geiger, Managing Partner
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Accelmed Partners II L.P. filed Form 4 for NeuroPace Inc (NPCE) on 23 Nov 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$585,046.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NPCE
transaction
Common Stock
Purchase
- Transaction value
- $491,512
- Shares
- +327,893
- Change %
- +8.1%
- Price
- $1.50
- Shares after
- 4,370,550
- Date
- 21 Nov 2022
- Ownership
- Direct
- Footnotes
- F1
NPCE
transaction
Common Stock
Purchase
- Transaction value
- $93,535
- Shares
- +62,398
- Change %
- +1.4%
- Price
- $1.50
- Shares after
- 4,432,948
- Date
- 22 Nov 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.